ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $192,624 | +113.9% | 64,208 | +166.7% | 0.01% | +116.7% |
Q2 2023 | $90,052 | -5.7% | 24,078 | -15.5% | 0.01% | 0.0% |
Q1 2023 | $95,475 | +32.6% | 28,500 | +179.5% | 0.01% | +200.0% |
Q2 2022 | $72,000 | -2.7% | 10,196 | -0.0% | 0.00% | 0.0% |
Q1 2022 | $74,000 | – | 10,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 2,485,638 | $22,222,000 | 1.76% |
EcoR1 Capital, LLC | 5,376,134 | $48,063,000 | 1.53% |
Cormorant Asset Management, LP | 1,679,442 | $15,014,000 | 0.89% |
CM Management, LLC | 100,000 | $894,000 | 0.68% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 596,800 | $5,335,000 | 0.40% |
PDT Partners, LLC | 278,487 | $2,490,000 | 0.19% |
Ikarian Capital, LLC | 116,600 | $1,043,000 | 0.16% |
HighVista Strategies LLC | 20,659 | $185,000 | 0.15% |
Aristides Capital LLC | 35,132 | $314,000 | 0.14% |
Parkwood LLC | 71,932 | $643,000 | 0.11% |